Michele A. Weidner‐Wells

1.4k total citations · 1 hit paper
19 papers, 1.1k citations indexed

About

Michele A. Weidner‐Wells is a scholar working on Organic Chemistry, Infectious Diseases and Pharmacology. According to data from OpenAlex, Michele A. Weidner‐Wells has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 5 papers in Infectious Diseases and 5 papers in Pharmacology. Recurrent topics in Michele A. Weidner‐Wells's work include Antimicrobial Resistance in Staphylococcus (5 papers), Synthesis and Biological Evaluation (5 papers) and Microbial Natural Products and Biosynthesis (4 papers). Michele A. Weidner‐Wells is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (5 papers), Synthesis and Biological Evaluation (5 papers) and Microbial Natural Products and Biosynthesis (4 papers). Michele A. Weidner‐Wells collaborates with scholars based in United States, Australia and Netherlands. Michele A. Weidner‐Wells's co-authors include Mark J. Macielag, Stephanie A. Fraga‐Spano, Greg Fulcher, Dick de Zeeuw, Kenneth W. Mahaffey, Hsiaowei Deng, Karen Bush, Ngozi Erondu, Wayne Shaw and David R. Matthews and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Tetrahedron.

In The Last Decade

Michele A. Weidner‐Wells

19 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials

2018 468 citations Vlado Perkovic, Dick de Zeeuw et al. The Lancet Diabetes & Endocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michele A. Weidner‐Wells United States	14	429	418	397	192	143	19	1.1k
Michael R. Leadbetter United States	11	29 0.1×	129 0.3×	280 0.7×	56 0.3×	99 0.7×	19	723
Tomoko Satoh Japan	14	100 0.2×	204 0.5×	240 0.6×	12 0.1×	15 0.1×	31	705
Peng Fu China	16	48 0.1×	113 0.3×	371 0.9×	76 0.4×	10 0.1×	45	954
William F. Demyan United States	11	144 0.3×	72 0.2×	302 0.8×	30 0.2×	7 0.0×	17	693
Garima Gupta India	24	27 0.1×	561 1.3×	427 1.1×	19 0.1×	32 0.2×	46	1.2k
Lawrence F. Colwell United States	19	108 0.3×	398 1.0×	555 1.4×	30 0.2×	3 0.0×	33	1.2k
J.A. Hernandez Prada United States	9	118 0.3×	192 0.5×	314 0.8×	19 0.1×	5 0.0×	13	892
Sheng Tang China	17	27 0.1×	237 0.6×	379 1.0×	27 0.1×	7 0.0×	43	752
Juan J. Martínez Medina Argentina	12	23 0.1×	133 0.3×	198 0.5×	114 0.6×	8 0.1×	27	757
Nuna Araújo Portugal	12	30 0.1×	198 0.5×	139 0.4×	48 0.3×	80 0.6×	20	709

Countries citing papers authored by Michele A. Weidner‐Wells

Since Specialization

Citations

This map shows the geographic impact of Michele A. Weidner‐Wells's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele A. Weidner‐Wells with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele A. Weidner‐Wells more than expected).

Fields of papers citing papers by Michele A. Weidner‐Wells

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele A. Weidner‐Wells. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele A. Weidner‐Wells. The network helps show where Michele A. Weidner‐Wells may publish in the future.

Co-authorship network of co-authors of Michele A. Weidner‐Wells

This figure shows the co-authorship network connecting the top 25 collaborators of Michele A. Weidner‐Wells. A scholar is included among the top collaborators of Michele A. Weidner‐Wells based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele A. Weidner‐Wells. Michele A. Weidner‐Wells is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Perkovic, Vlado, Dick de Zeeuw, Kenneth W. Mahaffey, et al.. (2018). Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials. The Lancet Diabetes & Endocrinology. 6(9). 691–704. 468 indexed citations breakdown →

Grant, Eugene B., Barbara D. Foleno, Raúl Goldschmidt, et al.. (2014). 7-(4-Alkylidenylpiperidinyl)-quinolone bacterial topoisomerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(23). 5502–5506. 5 indexed citations

Li, Xun, Ronald K. Russell, Tobias Schmid, et al.. (2010). An Improved Non-chromatographic Scale-up Synthesis of a New 1,6,7,8-Substituted-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid as a Potent Bacterial Topoisomerase Inhibitor. Organic Preparations and Procedures International. 42(2). 151–160. 1 indexed citations

Foleno, Barbara D., Raúl Goldschmidt, Dennis J. Hlasta, et al.. (2006). Antibacterial activity of pyrrolopyridine-substituted oxazolidinones: synthesis and in vitro SAR of various C-5 acetamide replacements. Bioorganic & Medicinal Chemistry Letters. 16(17). 4537–4542. 22 indexed citations

Bush, Karen, Mark J. Macielag, & Michele A. Weidner‐Wells. (2004). Taking inventory: antibacterial agents currently at or beyond Phase 1. Current Opinion in Microbiology. 7(5). 466–476. 87 indexed citations

Weidner‐Wells, Michele A., Harvey M. Werblood, Raúl Goldschmidt, et al.. (2004). The synthesis and antimicrobial evaluation of a new series of isoxazolinyl oxazolidinones. Bioorganic & Medicinal Chemistry Letters. 14(12). 3069–3072. 22 indexed citations

Weidner‐Wells, Michele A., Todd C. Henninger, Stephanie A. Fraga‐Spano, et al.. (2004). Synthesis and structure–activity relationships of 3,5-diarylisoxazoles and 3,5-diaryl-1,2,4-oxadiazoles, novel classes of small molecule interleukin-8 (IL-8) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(16). 4307–4311. 33 indexed citations

Foleno, Barbara D., Raúl Goldschmidt, Dennis J. Hlasta, et al.. (2003). Synthesis and antibacterial activity of pyrroloaryl-substituted oxazolidinones. Bioorganic & Medicinal Chemistry Letters. 13(23). 4173–4177. 37 indexed citations

Weidner‐Wells, Michele A., et al.. (2002). Novel piperidinyloxy oxazolidinone antibacterial agents. Diversification of the N-Substituent. Bioorganic & Medicinal Chemistry. 10(7). 2345–2351. 20 indexed citations

10.

Weidner‐Wells, Michele A., et al.. (2001). Novel piperidinyloxy oxazolidinone antimicrobial agents. Bioorganic & Medicinal Chemistry Letters. 11(14). 1829–1832. 13 indexed citations

11.

Weidner‐Wells, Michele A., Kwasi A. Ohemeng, Van N. Nguyen, et al.. (2001). Amidino benzimidazole inhibitors of bacterial two-component systems. Bioorganic & Medicinal Chemistry Letters. 11(12). 1545–1548. 111 indexed citations

12.

Hlasta, Dennis J., James P. Demers, Barbara D. Foleno, et al.. (1998). Novel inhibitors of bacterial two-component systems with gram positive antibacterial activity: Pharmacophore identification based on the screening hit closantel. Bioorganic & Medicinal Chemistry Letters. 8(14). 1923–1928. 56 indexed citations

13.

Macielag, Mark J., James P. Demers, Stephanie A. Fraga‐Spano, et al.. (1998). Substituted Salicylanilides as Inhibitors of Two-Component Regulatory Systems in Bacteria. Journal of Medicinal Chemistry. 41(16). 2939–2945. 111 indexed citations

14.

Weidner‐Wells, Michele A., Stephanie A. Fraga‐Spano, & Ignatius J. Turchi. (1998). Unusual Regioselectivity of the Dipolar Cycloaddition Reactions of Nitrile Oxides and Tertiary Cinnamides and Crotonamides¹. The Journal of Organic Chemistry. 63(18). 6319–6328. 44 indexed citations

15.

Weidner‐Wells, Michele A., Jeffrey Fernandez, Stephanie A. Fraga‐Spano, et al.. (1998). DNA gyrase inhibitory activity of ellagic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 8(1). 97–100. 16 indexed citations

16.

Weidner‐Wells, Michele A., Kazuaki Oda, & Paul H. Mazzocchi. (1997). The intramolecular electron transfer reactions of N-Alkylcyclopropyl phthalimides. Tetrahedron. 53(10). 3475–3486. 23 indexed citations

17.

Weidner‐Wells, Michele A. & Stephanie A. Fraga‐Spano. (1996). An Improved Method for the Preparation OF 3,5-Difluorosalicylaldehyde and 3,5-Difluorosalicylic Acid^#. Synthetic Communications. 26(14). 2775–2781. 8 indexed citations

18.

Weidner‐Wells, Michele A., et al.. (1994). Control of regioselectivity in nitrile oxide cycloadditions to cinnamic acid derivatives. Tetrahedron Letters. 35(35). 6473–6476. 9 indexed citations

19.

Weidner‐Wells, Michele A., Ann E. DeCamp, & Paul H. Mazzocchi. (1989). Photochemical approach to the synthesis of the pyrrolo[1,4]benzodiazepine antibiotics. The Journal of Organic Chemistry. 54(24). 5746–5758. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact